Results 21 to 30 of about 25,638 (254)

Effects of liraglutide on ANP secretion and cardiac dynamics

Endocrine Connections, 2023
To observe the effects of liraglutide (analog of glucagon-like peptide 1 (GLP-1)) on atrial natriuretic peptide (ANP) secretion and atrial dynamics, an ex vivo isolated rat atrial perfusion model was used to determine atrial ANP secretion and pulse ...
Shenghe Luo, Yunhui Zuo, Xiaotian Cui, Meiping Zhang, Honghua Jin, Lan Hong   +5 more
doaj   +1 more source

Efficacy of liraglutide in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials

BMC Endocrine Disorders, 2022
Background The efficacy of liraglutide to treat type 2 diabetic nephropathy (T2DN) remains controversial. Thus, we conducted this meta-analysis to systematically evaluate the clinical effect of liraglutide on T2DN patients.
Niroj Mali, Feng Su, Jie Ge, Wen Xing Fan, Jing Zhang, Jingyuan Ma   +5 more
doaj   +1 more source

A Glucagon-Like Peptide-1 Receptor Agonist Lowers Weight by Modulating the Structure of Gut Microbiota

Frontiers in Endocrinology, 2018
In addition to improving glucose metabolism, liraglutide, a glucagon-like peptide-1 receptor agonist, has weight-loss effects. The underlying mechanisms are not completely understood.
Li Zhao, Yi Chen, Fangzhen Xia, Buatikamu Abudukerimu, Wen Zhang, Yuyu Guo, Ningjian Wang, Yingli Lu   +7 more
doaj   +1 more source

Glucagon-like peptide analogues for type 2 diabetes mellitus : systematic review and meta-analysis [PDF]

, 2010
Background Glucagon-like peptide (GLP-1) analogues are a new class of drugs used in the treatment of type 2 diabetes. They are given by injection, and regulate glucose levels by stimulating glucose-dependent insulin secretion and biosynthesis ...
Deepson S Shyangdan, Christine Clar, Pawana Sharma, Royle, Pamela L, Sharma Pawana, Royle Pamela L, Clar, Christine, Clar, C., Waugh, Norman R, Waugh Norman R, Pamela L Royle, Shyangdan Deepson S, Clar Christine, Waugh, Norman, Norman R Waugh, Sharma, Pawana, Shyangdan, D. (Deepson), Shyangdan, Deepson S, Royle, Pamela   +18 more
core   +2 more sources

Mitigation of Blast-Induced Hearing Damage Associated with Mild-TBI Chinchillas using Liraglutide [PDF]

, 2022
Even with the use of hearing protection devices (HPDs), hearing damage caused by blast exposure dominates service-related disabilities faced by active service members and Veterans. Epidemiology studies have revealed that this hearing damage is associated
Sanders, Sarah
core  

Effect of hemodialysis on plasma glucose profile and plasma level of liraglutide in patients with type 2 diabetes mellitus and end-stage renal disease: a pilot study.

PLoS ONE, 2014
The effect of hemodialysis on the plasma glucose profile and liraglutide level after liraglutide injection was investigated in patients with diabetes and end-stage renal disease (ESRD).
Takeshi Osonoi, Miyoko Saito, Atsuko Tamasawa, Hidenori Ishida, Daisuke Tsujino, Rimei Nishimura, Kazunori Utsunomiya   +6 more
doaj   +1 more source

Liraglutide in the management of type 2 diabetes [PDF]

, 2010
Estela Wajcberg, Amatur AmarahPremier Nephrology and Hypertension, Internal Medicine Department, Trinitas Regional Medical Center, Elizabeth, New Jersey, USAAbstract: The pathophysiology of type 2 diabetes has been attributed to the classic triad of ...
null Amatur Amarah, Estela Wajcberg, Amatur Amarah   +2 more
core   +1 more source

Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis

Molecular Medicine, 2023
Background Non-alcoholic fatty liver disease (NAFLD) is one of the most common complications of type 2 diabetes mellitus (T2DM). The pathogenesis of NAFLD involves multiple biological changes, including insulin resistance, oxidative stress, inflammation,
Tingli Guo, Wenhui Yan, Xin Cui, Na Liu, Xiaotong Wei, Yuzhuo Sun, KeXin Fan, Jieyun Liu, Yuanyuan Zhu, Zhuanzhuan Wang, Yilei Zhang, Lina Chen   +11 more
doaj   +1 more source

Liraglutide ameliorates diabetes-associated cognitive dysfunction via rescuing autophagic flux

Journal of Pharmacological Sciences, 2021
The incidence of diabetes–associated cognitive dysfunction is increasing. However, few clinical interventions are available to prevent the disorder.
Meng Zhang, Wenhui Yan, Ye Yu, Jie Cheng, Xinyao Yi, Tingli Guo, Na Liu, Jia Shang, Zhuanzhuan Wang, Hao Hu, Lina Chen   +10 more
doaj   +1 more source

Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Ameliorates the Development of Periodontitis

Journal of Diabetes Research, 2020
Periodontitis is one of the diabetic complications due to its high morbidity and severity in patients with diabetes. The prevention of periodontitis is especially important in diabetic patients because the relationship between diabetes and periodontitis ...
Noritaka Sawada, Kei Adachi, Nobuhisa Nakamura, Megumi Miyabe, Mizuho Ito, Shuichiro Kobayashi, Shin-ichi Miyajima, Yuki Suzuki, Takeshi Kikuchi, Makoto Mizutani, Taku Toriumi, Masaki Honda, Akio Mitani, Tatsuaki Matsubara, Keiko Naruse   +14 more
doaj   +1 more source